Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenuePayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $4.8 million.

  • Coya Therapeutics' Total Liabilities rose 3435.54% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 3435.54%. This contributed to the annual value of $4.8 million for FY2024, which is 1522.65% down from last year.
  • Coya Therapeutics' Total Liabilities amounted to $4.8 million in Q3 2025, which was up 3435.54% from $5.1 million recorded in Q2 2025.
  • Coya Therapeutics' 5-year Total Liabilities high stood at $16.8 million for Q4 2022, and its period low was $1.2 million during Q2 2023.
  • Moreover, its 4-year median value for Total Liabilities was $4.8 million (2024), whereas its average is $5.0 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first crashed by 6648.62% in 2023, then surged by 29484.17% in 2024.
  • Over the past 4 years, Coya Therapeutics' Total Liabilities (Quarter) stood at $16.8 million in 2022, then plummeted by 66.49% to $5.6 million in 2023, then fell by 15.23% to $4.8 million in 2024, then dropped by 0.24% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $5.1 million for Q2 2025, and $5.0 million during Q1 2025.